Stay updated on Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial page.

Latest updates to the Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial page
- Check4 days agoChange DetectedPage now shows Revision: v3.4.2. The funding-lapse notice and the prior Revision: v3.4.1 text were removed.SummaryDifference0.2%

- Check11 days agoChange DetectedAdded a government funding/operational status banner notifying potential delays and that the NIH Clinical Center is open; also updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check19 days agoChange DetectedAdded a Show glossary toggle and new Last Update metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted) and updated the No FEAR Act Data notice. Revision updated to version 3.4.0.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4; no changes to study details or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded a Locations section listing study sites across the United States and Canada. Removed multiple location entries and the HHS Vulnerability Disclosure link, indicating consolidation of site listings.SummaryDifference2%

- Check82 days agoChange DetectedAdded explanatory text in Publications that PubMed entries are auto-filled and may not be about the study, with Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial page.